Minot Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,393
Closed -$277K 209
2021
Q3
$277K Sell
3,393
-183
-5% -$16.5K 0.06% 166
2021
Q2
$331K Sell
3,576
-2,895
-45% -$258K 0.07% 148
2021
Q1
$553K Sell
6,471
-1,565
-19% -$140K 0.14% 112
2020
Q4
$759K Sell
8,036
-729
-8% -$63.7K 0.23% 92
2020
Q3
$762K Sell
8,765
-10,035
-53% -$869K 0.29% 80
2020
Q2
$1.64M Buy
18,800
+5,375
+40% +$464K 0.82% 50
2020
Q1
$1.11M Sell
13,425
-1,292
-9% -$115K 0.79% 46
2019
Q4
$1.4M Buy
+14,717
New +$1.32M 0.64% 51

Other funds holding NVS

Minot Wealth Management's NVS Position: Q4 2021 in Review

Minot Wealth Management sold out of Novartis (NVS) in Q4 2021, closing a stake of 3,393 shares — an estimated $277K sold.

Minot Wealth Management first reported a position in NVS in Q4 2019 and held it in 8 quarters. The position peaked at $1.64M in Q2 2020. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

  • Minot Wealth Management reported no remaining Novartis position as of Q4 2021 after selling out during the quarter.
  • Minot Wealth Management sold 3,393 Novartis shares in Q4 2021, an estimated $277K.
  • Minot Wealth Management first reported a position in Novartis in Q4 2019 and held it in 8 quarters.
  • Minot Wealth Management's Novartis position peaked at $1.64M in Q2 2020.
  • 1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Minot Wealth Management's 13F filing for Q4 2021, filed 20 Jan 2022.